Salud financiera de hoja de balance de DexCom
Salud financiera controles de criterios 6/6
DexCom tiene un patrimonio de accionistas total de $2.1B y una deuda total de $2.4B, lo que sitúa su ratio deuda-patrimonio en 117.7%. Sus activos y pasivos totales son $6.3B y $4.2B respectivamente. El BAIT de DexCom es de $597.7M, por lo que su ratio de cobertura de intereses es de -5.2. Tiene efectivo e inversiones a corto plazo que ascienden a $2.7B.
Información clave
108.4%
Ratio deuda-patrimonio
US$2.44b
Deuda
| Ratio de cobertura de intereses | -5.1x |
| Efectivo | US$2.90b |
| Patrimonio | US$2.25b |
| Total pasivo | US$4.24b |
| Activos totales | US$6.48b |
Actualizaciones recientes sobre salud financiera
Is DexCom (NASDAQ:DXCM) Using Too Much Debt?
Mar 29
DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Dec 18DexCom (NASDAQ:DXCM) Could Easily Take On More Debt
Sep 13DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet
Jun 05These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely
Mar 03DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly
Nov 25Recent updates
If EPS Growth Is Important To You, DexCom (NASDAQ:DXCM) Presents An Opportunity
May 07DexCom: Attractive Discount After Strong Earnings Results
May 06Returns At DexCom (NASDAQ:DXCM) Are On The Way Up
Apr 25Why We're Not Concerned About DexCom, Inc.'s (NASDAQ:DXCM) Share Price
Apr 12DexCom Is Pricey For A Reason - Its Growth Story Reflects That
Apr 11Is DexCom (NASDAQ:DXCM) Using Too Much Debt?
Mar 29Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?
Mar 04DexCom: A Wealth Compounder In Healthcare
Feb 14DexCom: Stelo Stellar Outlook
Jan 17DexCom (NASDAQ:DXCM) Is Experiencing Growth In Returns On Capital
Jan 15DexCom, Inc. (NASDAQ:DXCM) Not Lagging Industry On Growth Or Pricing
Jan 01DexCom (NASDAQ:DXCM) Seems To Use Debt Rather Sparingly
Dec 18A Look At The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Dec 05At US$109, Is It Time To Put DexCom, Inc. (NASDAQ:DXCM) On Your Watch List?
Nov 21DexCom (NASDAQ:DXCM) Is Looking To Continue Growing Its Returns On Capital
Sep 28DexCom (NASDAQ:DXCM) Could Easily Take On More Debt
Sep 13Calculating The Fair Value Of DexCom, Inc. (NASDAQ:DXCM)
Aug 29Should You Think About Buying DexCom, Inc. (NASDAQ:DXCM) Now?
Aug 14DexCom (NASDAQ:DXCM) Has A Rock Solid Balance Sheet
Jun 05There's Been No Shortage Of Growth Recently For DexCom's (NASDAQ:DXCM) Returns On Capital
May 16Do DexCom's (NASDAQ:DXCM) Earnings Warrant Your Attention?
Mar 21These 4 Measures Indicate That DexCom (NASDAQ:DXCM) Is Using Debt Safely
Mar 03DexCom (NASDAQ:DXCM) Is Doing The Right Things To Multiply Its Share Price
Feb 13DexCom (NASDAQ:DXCM) Seems To Use Debt Quite Sensibly
Nov 25Returns Are Gaining Momentum At DexCom (NASDAQ:DXCM)
Oct 21Dexcom launches G7 glucose monitoring system in parts of Europe, Asia
Oct 04What Is DexCom, Inc.'s (NASDAQ:DXCM) Share Price Doing?
Sep 24DexCom: A High-Priced Medical Devices Company Remains Stuck In A Downtrend
Sep 21DexCom promotes technology chief Leach to COO
Aug 31DexCom (NASDAQ:DXCM) Has A Pretty Healthy Balance Sheet
Aug 01DexCom stock down ~7% after hours as Q2 results miss expectations
Jul 28Estimating The Intrinsic Value Of DexCom, Inc. (NASDAQ:DXCM)
Jul 13DexCom: I Wouldn't Buy The Dip
Jul 07Is It Time To Consider Buying DexCom, Inc. (NASDAQ:DXCM)?
Jun 24We Like These Underlying Return On Capital Trends At DexCom (NASDAQ:DXCM)
Jun 03Análisis de la situación financiera
Pasivos a corto plazo: Los activos a corto plazo ($4.4B) de DXCM superan a sus pasivos a corto plazo ($1.6B).
Pasivo a largo plazo: Los activos a corto plazo de DXCM ($4.4B) superan a sus pasivos a largo plazo ($2.6B).
Historial y análisis de deuda-patrimonio
Nivel de deuda: DXCM tiene más efectivo que su deuda total.
Reducción de la deuda: El ratio deuda-patrimonio de DXCM ha pasado de 152.3% a 117.7% en los últimos 5 años.
Cobertura de la deuda: La deuda de DXCM está bien cubierta por el flujo de caja operativo (30.7%).
Cobertura de intereses: DXCM gana más intereses de los que paga, por lo que la cobertura de pagos de intereses no es preocupante.